Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Pharmacological Research|November 21, 2025
Pyrazolone-based ERO1 inhibitors in ERO1-driven triple-negative breast cancer and SEPN1-related myopathy: Structure-activity relationship and therapeutic potentialMichele Retini, Alessandro Cherubini, Alice Marrazza, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2025
Targeting the Liver Serine Protease TMPRSS6 Ameliorates Steatosis and Attenuates Fibrosis in Experimental MASLDMariateresa Pettinato, Valeria Furiosi, Rossana Carleo, et al.
International Journal of Biological Sciences|December 12, 2024
Extracellular Vesicles from Human Induced Pluripotent Stem Cells Exhibit a Unique MicroRNA and CircRNA SignatureMario Barilani, Valeria Peli, Paolo Manzini, et al.
Nature Communications|March 20, 2024
Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memoryDaniela Michelatti, Sven Beyes, Chiara Bernardis, et al.
Nature Medicine|September 25, 2023
Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in womenAlessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, et al.
International Journal of Molecular Sciences|January 28, 2026
IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation ModulationFrancesco Malvestiti, Angela Lombardi, Francesco Gentile, et al.
Hepatology (Baltimore, Md.)|May 22, 2024
Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulationMary P Moore, Xiaobo Wang, John Paul Kennelly, et al.
Nature Metabolism|January 6, 2026
Hepatic GPR110 contributes to sex disparity in the development of MASH through oestrogen receptor α-dependent signallingFang Yang, Wei Wang, Feng Qiu, et al.
Cell Reports. Medicine|January 17, 2024
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoidsKavitha Sasidharan, Andrea Caddeo, Oveis Jamialahmadi, et al.
Cell Reports. Medicine|February 25, 2024
SEPN1-related myopathy depends on the oxidoreductase ERO1A and is druggable with the chemical chaperone TUDCASerena Germani, Andrew Tri Van Ho, Alessandro Cherubini, et al.
Pageof 8